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1. Introduction 
Loss of ion homeostasis plays an important role in the pathogenesis of ischemic cell 
damage. Ischemia induces accumulation of intracellular Na+ ([Na+]i) and Ca2+ ([Ca2+]i), 
and subsequent activation of proteases, phospholipases, and formation of oxygen and 
nitrogen free radicals. The Na+/H+ exchanger (NHEs) family is a group of secondary 
active membrane transport proteins that catalyze the electroneutral exchange of Na+ for 
H+ and is important in restoring intracellular pH (pHi) after ischemia-induced 
intracellular acidosis. Nine isoforms of NHE (NHE1-9) have been identified in 
mammalian tissues (Orlowski & Grinstein, 2004). These isoforms differ in their tissue 
expression, subcellular distribution, kinetic properties, inhibitor sensitivity, and 
physiological functions. NHE-1 is ubiquitously expressed on the plasma membrane of 
virtually all mammalian cell types (Sardet et al., 1989). NHE-2-4 are expressed on the 
plasma membrane, predominantly in the epithelia of the kidney and gastrointestinal tract 
(Orlowski & Grinstein, 2004). NHE-3 is the only isoform known to recycle between the 
plasma membrane and the endosomal compartment (D'Souza et al., 1998). NHE-5 
expression is concentrated in neurons (Attaphitaya et al., 1999) and may modulate the pH 
of synaptic vesicles (Szaszi et al., 2002). NHE-6 and NHE-9 are expressed predominantly 
in endosomal vesicles (Nakamura et al., 2005) and NHE-7 localizes to the trans-Golgi 
network and associated endosomes (Numata & Orlowski, 2001). NHE-8 has been 
localized to the plasma membrane of renal proximal tubule epithelial cells, and to 
endosomal vesicles and the trans-Golgi network (Goyal et al., 2003; Nakamura et al., 
2005). 
NHE-1 is the most extensively studied isoform, and the most abundant isoform in the CNS 
(Ma & Haddad, 1997; Orlowski et al., 1992). Research over the past two decades has 
expanded our understanding of the role of NHE-1 beyond that of simply maintenance of ion 
homeostasis and cell volume, to an emerging picture of a regulator of many cell functions. 
NHE-1 plays a role in regulation of cell proliferation, migration (Bussolino et al., 1989), and 
the microglial respiratory burst (Liu et al., 2010). NHE-1 protein consists of 815 amino acids 
with a calculated molecular weight of 85 kDa. However, NHE-1 has an apparent size of 
~110 kDa due to its N- and O- linked glycosylation in the extracellular loop 1. NHE-1 has 
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two large functional domains, the highly conserved amphipathic N-terminal domain (~500 
amino acids), which is responsible for cation translocation, and a less conserved hydrophilic 
cytoplasmic C-terminal domain (~315 amino acids), which is crucial for modulating NHE-1 
activity (Putney et al., 2002). Activation of NHE-1 has been shown to be a pivotal event in 
cell damage induced by ischemia and reperfusion in the brain (Horikawa et al., 2001; 
Hwang et al., 2008; Luo et al., 2005), heart (Liu et al., 1997; Murphy et al., 1991; Wang et al., 
2003), liver (Gores et al., 1989), and lungs (Rios et al., 2005). Here we will review recent 
findings implicating NHE-1 activation as a critical event in the pathogenesis of cellular 
dysfunction after cerebral ischemia, and the growing evidence supporting the use of NHE 
inhibitors as neuroprotective agents following cerebral ischemia.  
2. Na
+
/H
+
 Exchanger isoform-1 (NHE-1) in cerebral ischemia 
Ischemia and reperfusion injury is a complex and incompletely understood phenomenon. 
Ischemia deprives the cell of the energy required for normal cell function and leads to loss of 
ionic homeostasis within the cell due to opening of ionotropic glutamate receptors 
(Nishizawa, 2001) and acid sensing non-glutamate-dependent channels (Xiong et al., 2004), 
as well as activation of ion transport proteins such as NHE-1, Na+/K+/Cl- cotransporter 
(NKCCl) (Chen et al., 2005), and the Na+/Ca2+ exchanger (NCXs) (Hoyt et al., 1998). 
Reperfusion triggers a cascade of intracellular events including release of reactive oxygen 
species (ROS) and inflammatory mediators, which exacerbate injury and promote cell death. 
Ischemia and reperfusion induces intracellular acidosis due to a shift from aerobic to 
anaerobic glycolysis, and leads to an increase in [Na+]i and [Ca2+]i by mechanisms that 
include the activation of acid responsive ion transporters (Yao & Haddad, 2004). Recent 
findings from our group and others highlight the important role of NHE-1 in pHi regulation 
after cerebral ischemia and reperfusion. 
2.1 NHE-1 mediated intracellular pH regulation 
To regulate and maintain constant pHi, eukaryotic cells express plasma membrane ion 
transporters such as NHE-1 that protect cells from internal acidification by exchanging 
extracellular Na+ for intracellular H+ (Luo et al., 2005). At physiological pHi, NHE-1 is 
essentially inactive, despite the large inward Na+ gradient established by Na+/K+- ATPase. 
However, upon exposure to intracellular acidification, NHE-1 is rapidly activated and uses the 
electrochemical gradient of Na+ to pump H+ out of the cell and restore pHi. Upon restoration 
of pHi, NHE-1 activity returns to steady state levels (Pedersen, 2006). Extracellular acidification 
(low pHo) or removal of extracellular sodium suppresses this gradient-driven Na+/H+ 
exchange (Bobulescu et al., 2005). While NHE-1 serves to maintain homeostasis in the face of 
normal pHi fluctuations (which result from changes in metabolic activity), profound acidosis 
after anoxia can induce a NHE-1 mediated parodoxic alkalinization, a so-called “overshoot” of 
pHi restoration. We reported that post-anoxia alkalinization is ablated by pharmacological 
inhibition of NHE-1 and removal of extracellular sodium (Kintner et al., 2005). Protein kinase 
inhibitors attenuate this alkalinization, suggesting that activation of NHE-1 involves protein 
phosphorylation and multiple up-stream regulatory pathways such as extracellular signal-
regulated kinases (ERK 1/2), protein kinase A (PKA), and protein kinase C (PKC) (Kintner et 
al., 2005; Luo et al., 2007; Yao et al., 2001). 
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2.2 Ionic homeostasis and brain cell function 
Secondary active ion transport proteins are important in maintaining steady-state 
intracellular ion concentrations. NHE-1 plays an important role in regulation of many 
cellular processes in addition to pHi and cell volume regulation, such as cell growth, 
proliferation and differentiation, cell migration and adhesion, cellular immunity, and as 
cytoskeletal scaffolding for the assembly of intracellular signaling complexes (De Vito, 2006; 
Luo & Sun, 2007; Luo et al., 2005; Meima et al., 2007; Orlowski & Grinstein, 2004; Pedersen et 
al., 2006; Xue & Haddad, 2010). Due to their high metabolic rate and rapid changes in 
metabolic demand, neurons are exposed to frequent fluctuations in pHi, making efficient 
acid extrusion mechanisms essential for normal neuronal function. Neurons and astrocytes 
from mice deficient in the NHE-1 protein (NHE-1-/-) demonstrate decreased basal pHi and 
are unable to recover from an acid load (Luo et al., 2005). NHE-1 is the predominant NHE 
isoform in the CNS (Ma & Haddad, 1997; Orlowski et al., 1992), and as evidence of its 
importance in normal neurologic function, NHE-1-/- mice exhibit severe neurologic defects 
and seizures (Bell et al., 1999; Gu et al., 2001).  
2.3 Role of NHE-1 in cellular dysfunction and cerebral injury during in vivo ischemia 
Results from in vivo experimental studies support the importance of ion transport proteins 
in ischemia-mediated loss of ion homeostasis. NHE-1 activity in astrocytes (Cengiz et al., 
2010), neurons (Manhas et al., 2010), and microglia (Shi et al., 2011) is stimulated following 
cerebral ischemia. Excessive stimulation of NHE-1 leads to intracellular Na+ overload, and 
in turn causes a rise in intracellular Ca2+ due to increased Ca2+ influx via reversal of the 
Na/Ca exchanger. Thus, NHE-1 activity contributes to cerebral ischemic damage in part by 
disruption of intracellular Na+ and Ca2+ homeostasis, an event which is characterized by 
rapid influx of Ca2+ and subsequent cell death. 
2.3.1 Global ischemia 
Global cerebral ischemia entails diminution in cerebral blood flow (CBF) over the entire 
brain, and is encountered clinically in cardiac arrest. On restoration of CBF, a secondary 
reperfusion brain injury may occur due to altered ionic homeostasis, increases in ROS, 
cerebral edema, and inflammatory cascades (Schaller & Graf, 2004). The contribution of 
NHE-1 activity to global cerebral ischemia has been reported in a number of animal models. 
In a gerbil model of transient forebrain ischemia, NHE-1 immunoreactivity was markedly 
increased in CA1 pyramidal neurons as well as in glial cells 4 days following injury, and 
inhibition of NHE protected CA1 pyramidal neurons and attenuated the activation of 
astrocytes and microglia (Hwang et al., 2008). Yorkshire-Duroc pigs treated with cariporide 
(HOE 642), a potent and selective inhibitor of NHE-1, at the onset of a 90 min deep 
hypothermic circulatory arrest demonstrated improved neurologic recovery (Castellá et al., 
2005). Similarly, inhibition of NHE-1 with N-[aminoiminomethyl]-1-methyl-1H-indole-2-
carboxamide methanesulfonate (SM-20220) improved neurologic function in a gerbil model 
of transient global cerebral ischemia (Kuribayashi et al., 2000). Administration of the NHE-1 
inhibitor ethylisopropylamiloride (EIPA) prior to bilateral carotid artery occlusion in gerbils 
resulted in decreased hippocampal neuronal cell death and improved neurologic function 
(Phillis et al., 1999). 
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2.3.2 Focal ischemia 
Unlike global cerebral ischemia, focal cerebral ischemia entails reduction in regional CBF in 
a specific vascular territory and is usually encountered clinically as an “ischemic stroke” due 
to thromboembolic or vaso-occlusive disease. An abundance of in vivo studies support the 
importance of NHE-1 in focal ischemia. The NHE-1 inhibitor SM-20220 reduces infarct size 
in both transient and permanent focal ischemia models (Kuribayashi et al., 1999). Another 
NHE inhibitor, Sabiporide, reduces infarct size and edema volume when administered 
before or after ischemia (Park et al., 2005).  
Our investigations into the role of NHE-1 in cerebral ischemia have used both genetic and 
pharmacologic inhibition of NHE-1 in a mouse transient middle cerebral artery occlusion 
model (MCAO). Mice treated with HOE 642, a potent and selective inhibitor of NHE-1, prior 
to MCAO demonstrated a 35% reduction in infarct volume compared to vehicle treated 
controls. NHE-1 heterozygous mice (NHE-1+/-), which demonstrate a ~ 70% reduction in 
NHE-1 protein expression, exhibited a similar reduction in infarct volumes, establishing the 
importance of NHE-1 over other NHE isoforms in the CNS (Luo et al., 2005; Wang et al., 
2008). With T2-weighted and Diffusion Weighted MRI, we further confirmed that NHE-1+/+ 
mice treated with HOE 642 immediately prior to reperfusion or 60 minutes post-
reperfusiion, exhibited a significant reduction in infarct volume compared to NHE-1+/+ 
vehicle control mice. NHE-1+/- mice demonstrated a significant reduction in infarct volume 
on T2 MRI at 72 hours after injury (Ferrazzano et al., 2011). These findings suggest that 
elevated NHE-1 activity contributes to neuronal injury following ischemia and reperfusion. 
We subsequently revealed that focal cerebral ischemia triggers a transient stimulation of the 
extracellular signal-regulated kinase/p90 ribosomal S6 kinase (ERK/p90RSK) pathway that 
contributes to ischemic damage in part via phosphorylation of NHE-1 protein (Manhas et 
al., 2010). The NHE-1-mediated [Na+ ]i overload causes reverse function of the Na+/Ca2+ 
exchanger, elevating [Ca2+]i and enhancing the p38 mitogen-activated protein kinase 
(MAPK) and/or nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) (Liu 
et al., 2010). NHE-1 activity also plays a detrimental role in mitochondrial Ca2+ overload and 
mitochondrial dysfunction after ischemia as evidenced by attenuation of ischemia-induced 
cytochrome C release from mitochondria after NHE-1 inhibition (Wang et al., 2008). 
Interestingly, when NHE-1 activity is blocked either pharmacologically or by genetic 
knockdown, microglia activation and proinflammatory cytokine formation is significantly 
reduced in ischemic brains after MCAO (Shi et al., 2011). Taken together, these results 
strongly support that NHE-1 is activated after cerebral ischemia and worsens ischemic brain 
injury. 
2.3.3 Hypoxia/Ischemia 
Hypoxia-ischemia (HI) is a common cause of brain injury in neonates (Ferriero, 2004). We 
recently investigated the role of NHE-1 using a mouse model of neonatal hypoxia-ischemia 
as described by Vannucci (Vannucci & Vannucci, 2005). In these studies, post-natal day 9 
mice (P9) underwent unilateral carotid artery ligation and subsequent exposure to 55 
minutes of 8% O2. Following carotid ligation, mice were treated with HOE 642 either 
immediately before or 10 minutes following exposure to hypoxia (Cengiz et al., 2010). 
Following HI, vehicle-treated control brains exhibited astrogliosis in the ipsilateral 
hippocampus, and reactive astrocytes expressed an abundant level of NHE-1. Inhibition of 
NHE-1 before or after HI resulted in decreased neurodegeneration in striatum, thalamus 
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and hippocampus and improved performance on tests of motor learning and memory 
(Cengiz et al., 2010). These findings suggest that NHE-1 mediated disruption of ionic 
homeostasis can contribute to CA1 pyramidal neuronal injury after neonatal HI. Moreover, 
T2 weighted and Diffusion Tensor (DTI) MRI revealed that NHE-1 inhibition with HOE 642 
after HI resulted in improved white matter injury in the corpus callosum, which correlated 
with improvements in memory and learning (Cengiz et al., 2011). 
2.4 Role of NHE-1 in cellular dysfunction during in vitro ischemia 
Extensive in vitro studies have established that ischemia stimulates NHE-1 by reduction in 
pHi or via signaling pathways such as ERK-p90rsk, PKA or PKC (Dunbar & Caplan, 2001; 
Herrera et al., 1994; Kintner et al., 2007a; Li et al., 2004). The role of NHE-1 in cerebral 
ischemia has been mainly examined in two types of in vitro ischemic models, oxygen 
glucose deprivation/reoxygenation (OGD/REOX) or the hypoxic, acidic, ion-shifted 
Ringers’s solution (HAIR). Superfused brain slices also represent a useful preparation to 
study acid-base disturbance that occurs in the mammalian brain during in vitro ischemic 
conditions.  
2.4.1 Cell cultures 
NHE-1 activity is stimulated during in vitro ischemia and subsequent reoxygenation and 
contributes substantially to neuronal and glial cell injury. Acutely isolated CA1 neurons 
exhibit a tri-phasic response to 5 minutes of anoxia. During anoxia, an initial acidification 
progresses to alkalinization that is followed by further alkalinization on exposure to 
reoxygenation. This alkalinization is attenuated by reduction of external pH, removal of 
extracellular sodium, or inhibition of NHE-1 (Sheldon & Church, 2002; Yao et al., 2001). 
Additionally, inhibition of PKA can block post-anoxia alkalinization, suggesting cAMP-
dependent signaling pathways for NHE-1 activation (Sheldon & Church, 2002). 
We have demonstrated that NHE-1 is essential in pHi regulation using an internal acid load 
in cultured cortical neurons (Luo et al., 2005). Additionally, we found that activation of 
NHE-1 after OGD/REOX results in a significant increase in neuronal [Na+]i. This rise in 
[Na+]i following OGD is significantly attenuated in HOE 642-treated or NHE-1-/- neurons, 
and cell death is reduced (Luo et al., 2005). In a separate study, we demonstrated that NHE-
1-mediated Na+ entry leads to reverse activation of the Na+/Ca2+ exchanger (NCXrev) and 
rise in [Ca2+]i, which contribute to the selective dendritic vulnerability to in vitro ischemia 
(Kintner et al., 2010). Taken together, our studies suggest that NHE-1 activity in neurons is 
significantly stimulated in response to the metabolic acidification associated with an 
ischemic insult. This ischemia-induced increase in NHE-1 activity causes intracellular Na+ 
and Ca2+ overload, and eventually leads to cell death. 
In another series of studies, we examined the role of NHE-1 in ischemic astrocyte damage 
using OGD/REOX in cultured cortical astrocytes and found that NHE-1 is the primary pH 
regulatory mechanism after ischemia. Astrocyte NHE-1 activity is increased by ~ 1.8 fold 
during REOX (Kintner et al., 2004), and depends on ERK1/2 signaling pathways (Kintner et 
al., 2005). OGD/REOX results in a drop in pHi by 0.29 pH units (Kintner et al., 2004), and 
inhibition of NHE-1 results in a further decrease of pHi. Additionally, we observed that 
OGD/REOX triggers a ~5-fold increase in [Na+]i and 26% increase in astrocyte cell volume. 
This increase in [Na+]i and cell swelling are significantly reduced either with HOE 642 
treatment or in NHE-1-/- astrocytes (Kintner et al., 2004). Using the HAIR model in 
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astrocytes, we found a similar increase in [Na+]i which could be abolished by the NHE-1 
inhibitor HOE 642 (Kintner et al., 2007b). It has been reported that the expected rise in 
[Ca2+]i after HAIR exposure is inhibited by NHE-1 inhibition with HOE 694 (Bondarenko et 
al., 2005). Taken together, these results indicate that NHE-1 activity raises [Na+]i which 
fosters reversal of the Na+/Ca+ exchanger leading to increased intracellular Ca2+ and 
astrocyte cell death. 
More recently, new evidence supports a role of NHE-1 in microglial pHi regulation. 
Microglia activation by lipopolysaccharide (LPS), phorbol myristate acetate (PMA), or 
OGD/REOX triggers a concurrent stimulation of NHE-1 and NADPH oxidase (Liu et al., 
2010). The elevation in NHE-1-mediated H+ extrusion prevents intracellular acidosis, 
allowing for sustained NADPH oxidase function (Liu et al., 2010). Moreover, the coupling of 
NHE-1 activation with NCXrev activates [Na+]i and [Ca2+]i dependent signaling, which 
promotes the microglial respiratory burst and production of proinflammatory cytokines 
(Liu et al., 2010). 
2.4.2 Brain slice 
Few studies have used brain slice preparations to examine acid-base homeostatic 
disturbances during ischemia. In hippocampal slices, hypoxia induces a significant drop in 
both pHi and pHo, and a brief alkaline peak is also occasionally observed (Fujiwara et al., 
1992; Melzian et al., 1996; Roberts & Chih, 1997). In slice preparations from various brain 
regions, hypoxia causes acidosis with an approximately 0.8-1.2 pHi unit drop (Ballanyi et al, 
1996; Knopfel et al., 1998; Pirttila & Kauppinen, 1994). Cytosolic calcium changes are 
observed during ischemia in cortical brain slices that can be only partially inhibited by 
combined blockade of ion channels (Bickler and Hansen, 1994). Only one report shows a 
direct involvement of NHE mediated pHi regulation in slice preparations. In brainstem 
slices from neonatal rats exposed to 10 minutes of anoxia, intracellular pH drops by 0.1-0.3 
pH units in neurons. Inhibition of NHE with amiloride increases this anoxia-induced 
intracellular acidification (Chambers-Kersh et al., 2000). 
2.5 NHE-1 inhibitors and potential therapies 
Despite decades of research, the effective treatment and prevention of cerebral ischemic 
injury remains challenging. Inhibition of NHE-1 with either pharmacological agents or 
genetic ablation has been demonstrated to significantly reduce brain damage after ischemic 
insult, in both in vitro and in vivo models. These encouraging findings suggest the potential 
use of NHE inhibitors as neuroprotective therapies after cerebral ischemia.  
2.5.1 Pharmacological approach 
Two major classes of pharmacological agents are currently used to inhibit NHE-1 activity 
(Putney et al., 2002). The first class of drugs includes amiloride and its 5' alkyl-substituted 
derivatives (Counillon et al., 1993; Yu et al., 1993), such as ethylisopropylamiloride (EIPA), 
dimethylamiloride (DMA), 5-N (methylpropyl)amiloride (MPA), 5-(N-methyl-N-isobutyl)-
amiloride (MIBA), and 5-(N, N-hexamethylene) amiloride (HMA). These agents are more 
effective inhibitors of NHE-1 than amiloride but have relatively weak selectivity toward 
NHE-1. The simultaneous replacement of the pyrazine ring by a phenyl and of the 6-chloro 
by sulfomethyl leads to another class of inhibitors that includes the benzoylguanidines and 
derivatives such as HOE 694 (Counillon et al., 1993) and HOE 642 (cariporide) (Scholz et al., 
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1995). Both classes are more specific for NHE-1 than NHE-3, with the amiloride compounds 
demonstrating ~102-fold increased specificity and the HOE compounds ~103- to 105-fold 
more NHE-1 specificity. The HOE compounds are viewed as the most promising agents for 
treatment of ischemia-reperfusion injury due to their selectivity for NHE-1, and excellent 
solubility, resorption, and bioavailability profiles (Scholz et al., 1999; Baumgarth et al., 1997; 
Xue & Haddad, 2010). HOE compounds are competitive inhibitors of Na+ binding at the 
extracellular cation-binding site (Baumgarth et al., 1997; Counillon et al., 1993; Kinsella & 
Aronson, 1981; Mahnensmith & Aronson, 1985), while the amiloride derivatives also act 
non-competitively (Warnock et al., 1988). More recently, several new molecules have been 
designed as potential NHE blockers based on the bicyclic template, including SM-20220, 
SM-20550, BMS-284640, T-162559, and TY-12533, which have also shown promising results 
in in vivo studies of cerebral ischemia (Kitayama et al., 2001). The IC50 for the human NHE-1 
are as follows: Amiloride = 10.7 µM, Cariporide = 0.08 µM, T-165229 = 13 nM. Importantly, 
the NHE inhibitors HOE 642 and SM-20220 not only reduce cell death and edema, but also 
improve neurological function in in vivo ischemia models, and have demonstrated benefits 
when administered after ischemia (Kintner et al., 2007b; Kuribayashi et al., 2000).  
2.5.2 Transgenic approach 
While pharmacological studies indicate that NHE-1 plays a central role in cerebral ischemia-
reperfusion injury, the use of pharmacologic inhibitors to study ion transport function raises 
questions regarding dosing, absorption, species specific T1/2, and non-specific effects. For 
this reason, confirmation by an alternative method using NHE-1 knockdown mice is 
warranted. NHE-1-/- mice exhibit neurologic abnormalities, seizures, ataxia, and growth 
retardation, and do not survive into adulthood (Bell et al., 1999; Gu et al., 2001). Therefore, 
NHE-1-/- mice are useful for cultures of NHE-1 null neurons, astrocytes and microglia, but 
cannot be used for in vivo studies. NHE-1+/- mice express <50% of NHE-1 protein levels, and 
are useful for in vivo studies of the role of NHE function after cerebral ischemia. A marked 
decrease of infarct volume, microglial activation and proinflammatory cytokine formation is 
found in NHE-1+/- mice after MCAO (Luo et al., 2005). NHE-1 +/- and NHE-1 -/- cortical 
neurons and astrocytes demonstrate decreased cell death after OGD/REOX (Luo et al., 
2005).  
The fact that NHE-1 inhibitors applied during or after cerebral ischemia protect the brain 
against ischemic damage is now well established in animal studies. Despite the uniformity 
of results from animal models, a number of challenges remain before NHE-1 inhibitors can 
be translated into clinical use. Questions regarding safety, optimal dose, and timing of 
administration remain to be addressed, and large animal studies demonstrating improved 
functional outcomes are still lacking.  
3. Conclusion 
NHE-1 plays a pivotal role in maintaining tissue ionic homeostasis under normal 
physiological conditions. However, excessive stimulation of NHE-1 appears to be a major 
contributor to cellular damage in ischemic conditions. The proposed mechanism for injury 
induced by NHE-1 activation includes accumulation of [Na+]i, subsequent [Ca2+]i overload 
via reverse activation of the Na+/Ca2+ exchanger, and eventual cell death. Additionally, 
activation of MAPKs, and release of excitatory amino acids and ROS also contribute to cell 
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damage and death after ischemia. NHE-1 inhibitors have been demonstrated to be 
neuroprotective in both in vitro and in vivo ischemia models, making NHE-1 an attractive 
therapeutic target for cerebral ischemia. Thus, mechanisms of NHE-1 activation in ischemia 
continue to present an interesting focus for future research in this field. 
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